Local Adverse Reactions Decreased Over Time During Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Immunoglobulin G (FSCIG) Treatment in Patients with PID

被引：0

|

作者：

Stein, Mark ^{[1
]}

Wasserman, Richard L. ^{[2
]}

Melamed, Isaac ^{[3
]}

Gupta, Sudhir ^{[4
]}

Kobrynski, Lisa ^{[5
]}

Rubinstein, Arye ^{[6
,7
]}

Rabbat, Christopher J. ^{[8
]}

Engl, Werner ^{[9
]}

McCoy, Barbara ^{[10
]}

Leibl, Heinz ^{[9
]}

Yel, Leman ^{[10
]}

机构：

[1] Allergy Associates Palm Beaches, North Palm Beach, FL USA

[2] Allergy Partners North Texas Res, Dallas, TX USA

[3] IMMUNOe Hlth Ctr, Centennial, CO USA

[4] Univ Calif Irvine, Irvine, CA USA

[5] Emory Univ, Atlanta, GA 30322 USA

[6] Albert Einstein Coll Med, Bronx, NY 10467 USA

[7] Montefiore Hosp, Bronx, NY USA

[8] Shire, Chicago, IL USA

[9] Shire, Vienna, Austria

[10] Shire, Cambridge, MA USA

来源：

JOURNAL OF CLINICAL IMMUNOLOGY | 2017年 / 37卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

PO - 136

引用

收藏

页码：S54 / S54

页数：1

相关论文

共 43 条

[41] A PHASE III STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF RECOMBINANT HUMAN HYALURONIDASE (rHuPH20)-FACILITATED SUBCUTANEOUS (SC) INFUSION OF IMMUNOGLOBULIN (IG) (IGHY) FOR THE TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY (CIDP)
Sommer, C.
England, J.
Jakobsen, J.
Reeve, R.
Oh, M. S.
Ngo, L. Y.
Tobias, K.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 (02) : 235 - 235
[42] Long-Term Tolerability and Safety Of Facilitated-Subcutaneous Infusion Of Human Immune Globulin G (IgG), 10%, and Recombinant Human Hyaluronidase (rHuPH20) (IGHy): A Phase 3 Extension Study In Patients With Primary Immunodeficiencies (PIs)
Melamed, Isaac Reuven
Wasserman, Richard L.
Stein, Mark
Rubinstein, Arye
Puck, Jennifer M.
Gupta, Sudhir
Engl, Werner
Leibl, Heinz
Yel, Leman
Schiff, Richard I.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB180 - AB180
[43] RECOMBINANT HUMAN HYALURONIDASE [RHUPH20]-FACILITATED SUBCUTANEOUS (SC) INFUSION OF IMMUNO GLOBULIN G (IGG) (HYQVIA; IGHY) IN PATIENTS AGED ≥16 YEARS WITH PRIMARY IMMUNODEFICIENCIES (PI): LONG TERM SAFETY, EFFICACY, AND TOLERABILITY.
Wasserman, R. L.
Stein, M.
Melamed, I.
Kobrynski, L.
Grant, J. A.
Gupta, S.
Engl, W.
Leibl, H.
Yel, L.
Schiff, R. I.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (05) : A89 - A89

← 1 2 3 4 5 →